Minimum quality standards in global health. Impact and incentives

Table of Contents

1 Introduction

2 Global Health Organizations and Quality Standards

2.1 UNICEF

2.2 The Global Fund

2.3 World Health Organization

3 Theoretical Models on Minimum Quality Standards

3.1 Competition in a Duopoly

3.2 Competition with more than two Firms

3.3 Market Entry and Innovation

3.4 Limitations of the Models and Implications for Global Health

4 Incentives: Push and Pull Mechanisms

4.1 Advance Market Commitment

4.2 Priority Review Voucher

4.3 Health Impact Fund

4.4 R&D Tax Credits and Research Grants

4.5 Discussion

5 Conclusion

Objectives & Core Topics

This thesis examines the impact of implementing Minimum Quality Standards (MQS) on market participants within the global health sector. It investigates how such standards affect pharmaceutical manufacturers regarding market entry, product innovation, and profitability, while simultaneously addressing the tension between the requirement for high-quality medicines and the need for affordable supply. Finally, it analyzes how incentive mechanisms, categorized into push and pull strategies, can mitigate potential drawbacks of MQS introduction.

• Analysis of quality assurance requirements by organizations like UNICEF and the Global Fund.
• Game-theoretical modeling of MQS effects on price, quantity, and firm competition.
• Investigation of market entry barriers and innovation disincentives caused by stringent quality standards.
• Evaluation of push mechanisms (e.g., R&D tax credits) and pull mechanisms (e.g., Advance Market Commitment, Health Impact Fund).
• Synthesis of strategies to balance quality compliance with sustainable supply and manufacturer incentives.

Excerpt from the book

Summary of Chapters

1 Introduction: Introduces the challenge of providing essential medicines in developing countries and outlines the research objective of analyzing the effects of minimum quality standards.

2 Global Health Organizations and Quality Standards: Details the procurement processes and quality assurance requirements of UNICEF, the Global Fund, and the World Health Organization.

3 Theoretical Models on Minimum Quality Standards: Presents and compares various game-theoretical models to evaluate how MQS influence competition, market entry, and innovation.

4 Incentives: Push and Pull Mechanisms: Examines diverse financing and reward instruments designed to encourage pharmaceutical research and market participation.

5 Conclusion: Summarizes the findings on the trade-offs of quality standards and discusses how push and pull mechanisms can effectively address these challenges.

Keywords

Minimum Quality Standard, Global Health, Pharmaceutical Procurement, Game Theory, Duopoly, Market Entry, Innovation, Push Mechanisms, Pull Mechanisms, Advance Market Commitment, Health Impact Fund, Priority Review Voucher, R&D Tax Credits, Quality Assurance, Competition

Frequently Asked Questions

What is the core focus of this thesis?

The thesis addresses the dilemma faced by global health organizations: ensuring high quality of essential medicines while maintaining affordability and a sufficient supplier base.

What are the central thematic areas discussed?

The work covers pharmaceutical quality standards, competitive market modeling, and incentive structures to foster innovation in neglected disease drug development.

What is the primary objective or research question?

The goal is to determine how the introduction of Minimum Quality Standards (MQS) impacts market participants and how incentive mechanisms can alleviate the negative effects of these standards.

Which scientific method is utilized?

The thesis primarily uses a literature-based analysis and synthesis of game-theoretical microeconomic models to describe the real-world effects of market regulation.

What topics are covered in the main section?

The main part covers the quality assurance systems of major organizations, theoretical models of firm competition under MQS, and detailed discussions on push and pull incentive mechanisms.

Which keywords characterize this work?

The work is defined by concepts such as MQS, global health, pharmaceutical innovation, market failure, and economic incentive strategies like Advance Market Commitments.

How does the introduction of an MQS specifically affect firm profits?

The analysis indicates that an MQS often leads to increased competition and costs, which can decrease the profits of high-quality firms and potentially drive them to seek more profitable, less regulated markets.

Why are "Push" and "Pull" mechanisms considered essential?

They are necessary to correct market failures, such as time-inconsistency and the lack of research incentives for neglected diseases, by reducing financial risk or rewarding successful product development.